The 2022 CDC Opioid Prescribing Guidelines released on November 3, 2022, replaced earlier guidelines that had led to confusion, misinterpretation, and faulty application by medical providers, according to a statement from the RLS Foundation.
A patient writes into the Mayo Clinic News Network to ask if their child might be experiencing restless legs syndrome.
The International Restless Legs Syndrome Study Group published consensus guidelines on rodent models of RLS.
Typically, restless legs syndrome (RLS) affects one leg or both legs. But sometimes it can affect other areas of the body, such as the arms and torso. When this happens, it’s usually a sign that the condition is worsening.
Read More
Undergoing dialysis to treat kidney failure doesn’t always reduce symptoms of kidney failure, and it can sometimes make some symptoms worse.
Read More
The RESTFUL Study is a two-phase, randomized, double-blind, sham-controlled clinical trial to evaluate the company’s wearable NTX100 Neuromodulation System in patients with moderate-severe primary RLS.
Read MoreKorea Biomedical Review: Researchers at Seoul National University Hospital have discovered a biomarker that causes restless legs syndrome.
Read More
Sleep issues in children with autism are often written off as behavioral problems, but emerging science is unraveling a more complex picture.
Read More
The RLS Foundation is hosting a webinar on the “Brain Donor Project” with Tish Hevel, CEO of The Brain Donor Project, who will discuss what brain donation is and how patients can donate their tissue to further RLS research.
Read More
A patient with restless legs syndrome writes into The Seattle Times’ Wellness section to ask about how the COVID-19 Moderna vaccine could impact her symptoms.
Read More
Four in 10 don’t feel treatment options are clearly explained and 45% aren’t in complete agreement with their HCP on their RLS severity.
Read More
Pregnant women often develop restless legs syndrome (RLS), however the incidence of RLS in this population was associated with ethnicity, age, and nutritional factors according to study results published in Neurology.
Read More
Relaxis, a vibratory counterstimulation device for RLS patients that was FDA cleared in 2014, is no longer filling new prescriptions.
Read More
Restless legs syndrome pioneer Richard Allen died on Dec 9, 2020, with his family by his side.
Read MoreDignity Memorial: Restless legs syndrome pioneer Riichard Putnam Allen, 82, of Arnold, Maryland, passed away on December 9, 2020 at home, with his family by his side.
Read MoreNoctrix Health is developing a neuromodulation-based approach to treat RLS and has obtained a Breakthrough Device Designation from the FDA.
Read MorePenn State investigators found differences between different racial and ethnic groups and the prevalence of restless legs syndrome during pregnancy, but they do not believe that race was the cause of the differences.
Read More
A patent proposes a new treatment method that targets the increased D1 receptor levels in RLS patients experiencing augmentation.
Read More